Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial

Overview of attention for article published in Frontiers in Pharmacology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,329 followers.

3/ In a randomized trial comparing midodrine/octreotide with intravenous norepinephrine for treatment of type I hepatorenal syndrome, those in the norepinephrine arm had improvement in serum creatinine at a significantly greater frequency https://t.co/DI3l

03 Jun 2023

Reply Repost Favourite

New Research: Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial https://t.co/oCC58kV5CZ #pharmacology

02 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.